Comparison of triple quadrupole and high-resolution TOF-MS for quantification of peptides

Bioanalysis

Volumn 4, Issue 5, 2012, Pages 565-579

  Dillen, Lieve ^a   Cools, Willy ^a   Vereyken, Liesbeth ^a   Lorreyne, Willy ^a   Huybrechts, Tinne ^a   De Vries, Ronald ^a   Ghobarah, Hesham ^b   Cuyckens, Filip ^a  

^a JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

^b MDS SCIEX   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

C34; ENFUVIRTIDE; EXENDIN 4; GLUFIBRINOPEPTIDE B; PEPTIDE DERIVATIVE; SOMATOSTATIN; TRI 1144; UNCLASSIFIED DRUG;

ACCURACY; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG DETERMINATION; INTERMETHOD COMPARISON; LIMIT OF QUANTITATION; MOLECULAR WEIGHT; PEPTIDE ANALYSIS; PROCESS OPTIMIZATION; QUADRUPOLE MASS SPECTROMETRY; QUALITY CONTROL; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; SENSITIVITY ANALYSIS; SUPERNATANT; TIME OF FLIGHT MASS SPECTROMETRY;

CHROMATOGRAPHY, LIQUID; HIV ENVELOPE PROTEIN GP41; HUMANS; LIMIT OF DETECTION; MASS SPECTROMETRY; PEPTIDE FRAGMENTS; PEPTIDES; SOMATOSTATIN; STEROIDS; VENOMS;

EID: 84858392049     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.12.3     Document Type: Article

References (31)

1. Vlieghe P, Lisowski V, Marinez J, Khrestchatisky M. Syntheic therapeutic peptides:science and market. Drug Discov. Today 15, 40-56 (2010
2. Peptide Therapeutic Foundation: Reichert J, Pechon P, Tartar A, Dunn M. Development trends for peptide therapeutics; a comprehensive quantitative analysis of peptide therapeutics in clinical development (report summary) (2010
3. Van den Broek I, Sparidans RW, Schellens JHM, Beijnens JH. Sensitive liquid chromatography-tandem mass spectrometry assay for absolute quantification of ITIH4-derived putative biomarker peptides in clinical serum samples. Rapid Comm. Mass Spectrom. 24(13), 1842-1850 (2010
4. Van den Broek I, Sparidans RW, Schellens JHM, Beijnens JH. Quantitative assay for six potential breast cancer biomarker peptides in human serum by liquid chromatography coupled to tandem mass spectrometry. J. Chromatogr. B 878, 590-602 (2010
5. Dillen L, Cools W, Vereyken L, Timmerman P. A screening UHPLC-MS/MS method for the analysis of amyloid peptides in cerebrospinal fluid of preclinical species. Bioanalysis 3(1), 45-55 (2011
6. Hoofnagle A, Wener M. The fundamental flaws of immunoassays and potential solutions using tandem mass spectrometry. J. Immunol. Meth. 347, 3-11 (2009
7. MacLean B, Tomazela DM, Abbatiello SE et al. Effect of collision energy optimization on the measurement of peptides by selected reaction monitoring (SRM) mass spectrometry. Anal. Chem. 82, 10116-10124 (2010
8. Shipkova P, Drexler D, Langlish R, Smalley J, Salyan M, Sanders M. Application of ion trap technology to liquid chromatography/mass spectrometry quantitation of large peptides. Rapid Commun. Mass Spectrom. 22, 1359-1366 (2008
9. Vatansever B, Lahrichi SL, Thiocone A et al. Comparison between a linear ion trap and a triple quadruple MS in the sensitive detection of large peptides at femtomole amounts on column. J. Sep. Sci. 33, 2478-2488 (2010
10. Klaassen T, Swandt S, Kapron JT, Roemer A. Validated quantitation method for a peptide in rat serum using liquid chromatography/high field asymmetric waveform ion mobility spectrometry. Rapid Commun. Mass Spectrom. 23, 2301-2306 (2009
11. Schneider BB, Covey TR, Coy SL, Krylov EV, Nazarov EG. Chemical effects in the separation process of a differential mobility/mass spectrometer system. Anal. Chem. 82, 1867-1880 (2010
12. Varesio, Y. LeBlanc J-C., Hopfgartner G. Real-time 2D separation by Lc X differential ion mobility hyphenated to mass spectrometry. Anal. Bioanal. Chem. doi:10.1007/s00216-011-5444-y (2011) (Epub ahead of print
13. Hopfgartner G. Can MS fully exploit the benefits of fast chromatography. Bioanalysis 3(2), 121-123, (2011
14. Hao C, Campbell JL, Verkerk UH, Le Blanc JCY, Siu KWM. Performance and attributes of liquid chromatography-mass spectrometry with targeted charge separation in quantitative analysis of therapeutic peptides. J. Am. Soc. Mass Spectrom. 22(1), 67-74 (2011
15. Campbell JL, Le Blanc JCY. Targeted ion parking for the quantitation of biotherapeutic proteins: Concepts and preliminary data. J. Am. Soc. Mass Spectrom. 21(12), 2011-2022 (2010
16. O'Connor D, Mortishire-Smith R. High-throughput bioanalysis with simultaneous acquisition of metablic route data using ultra performance liquid chromatography coupled with time-of-flight mass spectrometry. Anal. Bioanal. Chem. 385, 114-121 (2006
17. Kaufmann A, Butcher P, Maden K, Walker S, Widmer M. Quantitative and confirmative performance of liquid chromatography coupled to high resolution mass spectrometry compared with tandem mass spectrometry. Rapid Commun. Mass Spectrom. 25(7), 979-992 (2011
18. Soler C, Hamilton B, Furey A, James KJ, Manes J, Pico Y. Comparison of four mass analyzers for determining carbosulfan and its metabolite in citrus by liquid chromatography-mass spectrometry. Rapid Commun. Mass Spectrom. 20, 2151-2164 (2006
19. Kadar H, Veyrand B, Barbarossa A et al. Development of an analytical strategy based on liquid chromatography-high resolution mass spectrometry for measuring perfluorinated compounds in human breast milk: Application to the generation of preliminary data regarding perinatal exposure in France. Chemosphere. doi:10.1016/j.chemosphere.07.077 (2011) (Epub ahead of print
20. Jiwan JLH, Wallemacq P, Herent MF. HPLC-high resolution mass spectrometry in clinical laboratory? Clin. Biochem. 44, 136-147 (2011
21. Taillon MP, Furtado M, Garofolo F. Challenges of developing a bioanalytical method for a macrolide immunosuppressant compound by LC-MS/MS. Bioanalysis 3(1)1, 1201-1215 (2011
22. Fung E, Xia Y-Q, Aubry A-F et al. Full scan high resolution accurate mass spectrometry (HRMS) in regulated bioanalysis: LC-HRMS for the quantitation of prednisone and prednisolone in human plasma. J. Chromatogr. B 879, 2919-2927 (2011
23. Korfmacher W. High resolution mass spectrometry will dramatically change our drug-discovery bioanalysis procedures. Bioanalysis 3(11), 1169-1171 (2011
24. Ramanathan R, Jemal M, Ramagiri S et al. It is time for a paradigm shift in drug discovery bioanalysis: From SRM to HRMS. J. Mass Spectrom. 46, 595-601 (2011
25. Zhang N, Yu S, Tiller P, Yeh S, Mahan E, Emary W. Quantitation of small molecules using high-resolution accurate mass spectrometers - a different approach for analysis of biological samples. Rapid Comm. Mass Spectrom. 23(7), 1085-1094 (2009
26. Bateman K, Kellman M, Muenster H, Papp R, Taylor L. Quantitative- qualitative data acquisition using a benchtop Orbitrap mass spectrometer. J. Am. Soc. Mass Spectrom. 20(8), 1441-1450 (2009
27. Van den Broek I, Sparidans R, Schellens J, Beijnen J. Quantitative bioanalysis of peptides by liquid chromatography coupled to tandem mass spectrometry. J. Chromatogr. B 872, 1-22 (2008).
28. Ewles M, Goodwin L. Bioanalytical approaches to analyzing peptides and proteins by LC-MS/MS. Bioanalysis 3(12), 1379-1397 (2011
29. Campbell JL, Le Blanc JCY. Peptide and protein drug analysis by MS: Challenges and opportunities for the discovery environment. Bioanalysis 3(6), 645-657 (2011
30. Xia Y-Q, Lau J, Olah T, Jemal M. Targeted quantitative bioanalysis in plasma using liquid chromatography/high-resolution accurate mass spectrometry: An evaluation of global selectivity as a function of mass resolving power and extraction window, with comparison of centroid and profile modes. Rapid Commun. Mass Spectrom. 25, 2863-2828 (2011).
31. Wang G, Cole RB. Mechanistic interpretation of the dependence of charge state distributions on analyte concentrations in electrospray mass spectrometry. Anal. Chem. 67, 2892-2900 (1995).